NBTX
Nanobiotix S.A.
NASDAQ · Healthcare · Biotechnology · FR
$38.80
−3.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 17.52x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -20.07x
- Price / sales
- 75.53x
- Price / cash flow
- -32.01x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 77.43x
- EV / EBITDA
- -21.94x
- EV / EBIT
- -21.95x
- Market cap
- $2.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025